Canopy Growth Stock Falls 13% as Revenue Falls 25% on Lower Sales

Canopy Growth (TSX:WEED)(NASDAQ:CGC) stock beat earnings estimates in Q4 but saw net revenue drop year over year by 25%.

| More on:
Pot stocks are a riskier investment

Image source: Getty Images

Canopy Growth (TSX:WEED)(NASDAQ:CGC) shares fell by 13% on Friday market open, as the company reported shrinking revenue on a year-over-year basis.

  • Canopy Growth stock beat earnings estimates of a loss of $0.31, posting a loss of $0.28 per share.
  • Net revenue fell 25% in the fourth quarter from the same time in 2021.
  • On a full-year basis, Canopy Growth stock reported $520 million in net revenue, down 5% from FY2021.

What happened in Q4 and FY2022 for Canopy Growth stock?

Canopy Growth stock climbed ahead of earnings on Thursday, up 11% at the close of the market. Analysts estimated the cannabis stock would bring in about $129 million in net revenue, yet the stock posted net revenue of $111.8 million for the fourth quarter. This resulted in shares losing all that growth by the time the market opened on Friday.

For the year, the net loss amounted to $320 million, a $1.35 billion improvement from full-year 2021. This came from fair-value changes and lower operating costs that included restructuring. Still, adjusted EBITDA increased to a loss of $122 million due to lower sales in Q4 and a loss of $415 million in FY2022. That was an increase of $75 million from the year before again from lower sales.

What did Canopy Growth management say?

The main goal of Canopy Growth stock remains to become profitable. From that, the company believes its BioSteel brand and further United States expansion will help create that profitability now that so many costs have been cut. It now maintains the number one spot of cannabis edibles in North America.

“We’ve taken concrete steps to advance this ambition by strengthening our positioning in Canada, and further bolstering our U.S. THC ecosystem through the addition of two high performance brands in Wana Brands and Jetty Extracts. In the fiscal year ahead, we will remain focused on growing our market share in the key segments that will drive profitable growth and continuing to scale our premium brands across North America.”

David Klein, chief executive officer of Canopy Growth

What’s next for Canopy Growth stock?

Analysts remain unconvinced about the future of Canopy Growth stock. In fact, even before earnings some analysts stated they hoped to see more cost-cutting initiatives. However, that doesn’t seem to have come to fruition.

Instead, it looks like it’s back to spending on expanding their edibles brands throughout North America, especially in the United States. But as for the next quarter, it’s likely lower sales will continue. Meanwhile, even though it’s still operating at a high loss, the company is back to focusing on investments in FY2023.

It looks like investors weren’t thrilled by the news with shares dropping immediately at the time of market open. Shares were down 13% at the time of writing and down 41% year to date.

Fool contributor Amy Legate-Wolfe has positions in Canopy Growth Corp. The Motley Fool has no position in any of the stocks mentioned.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »